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Abstract:
Objective:
Sex hormone binding globulin (SHBG) is a marker of insulin resistance. Given established links between BMI and socioeconomic
disadvantage, we investigated how SHBG varies by index of multiple deprivation (IMD).
Research Design and Methods:
Using laboratory data from a Midlands UK population of mixed ethnicity, we examined the relation between blood concentrations of
SHBG and IMD in 1160 women aged between 17 and 71 years. Women with a serum SHBG >250 nmol/L were excluded.
Results:
Mean age was 28.7 (95% confidence interval (CI) 28.2–29.1) years. 48.2% of women were of Caucasian origin, 15.5% of Southern
Asian ethnicity and 2.6% were of African or other origin (33.7% were of unknown origin).
SHBG increased with age (Spearman’s ρ=0.195; p<0.001). A higher proportion of women of South Asian origin versus other ethnic
groups had an SHBG <30 nmol/L (OR 1.93 (95% CI 1.37–2.71)).
SHBG level was lower in individuals with greater socioeconomic disadvantage as measured by IMD (Spearman's ρ= -0.09; p=0.004
for SHBG versus IMD).
In multivariate logistic regression, IMD women in the quartiles 2–5 (higher socioeconomic disadvantage) were more likely to have
an SHBG <30 nmol/L (compatible  with significant  insulin  resistance)  versus  quartile  1  (odds ratio  (OR) 1.71 (95% confidence
interval (CI) 1.17–2.53), adjusted for age (OR=0.97 (95% CI 0.95–0.98)) and ethnicity (for South Asian ethnicity OR=2.00 (95% CI
1.42–2.81) versus the rest).
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Conclusion:
Lower SHBG levels  in women are associated with a  higher level  of  socioeconomic disadvantage.  Given the known association
between lower SHBG and higher plasma glucose, our findings suggest a link between socioeconomic disadvantage and future risk of
type 2 diabetes.
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INTRODUCTION
Sex hormone binding globulin (SHBG) is the principal transport  protein for testosterone and oestradiol.  Recent
research, however, suggests that SHBG has additional biological significance. Low SHBG concentrations are associated
with an increased risk of development of type 2 diabetes mellitus (T2DM) [1]. Low circulating SHBG levels are also
associated with insulin resistance [2], itself a characteristic feature of T2DM with insulin resistance playing a major role
in its pathogenesis [3].
SHBG is a 90-kDa glycoprotein composed of two 373 amino acid subunits, each with a single steroid binding site.
Its  principal  function has  traditionally  been considered to  be  that  of  a  transport  protein  for  sex  steroids,  regulating
circulating  concentrations  of  free  (unbound)  hormones  and  their  transport  to  target  tissues.  SHBG  is  primarily
synthesized in the liver with its production downregulated by insulin [4]. Metabolic clearance from the intravascular
compartment is biphasic with the initial clearance occurring over hours and further clearance over a half-life of several
days. Glycosylation prolongs serum half-life [5].
Both prospective and cross-sectional studies have reported an association between low serum SHBG concentration
and  an  increased  risk  of  development  of  T2DM [6].  Of  these,  23  cross-sectional  and  10  prospective  studies  were
included in a 2006 systematic review and meta-analysis by Ding et al. [1] which reported that a higher concentration of
SHBG  was  associated  with  a  lower  risk  of  development  of  T2DM,  and  that  this  relation  was  stronger  for  post-
menopausal women than for men.
The homeostasis model assessment of insulin resistance (HOMA-IR) using fasting insulin and glucose levels can be
used  to  estimate  insulin  resistance  [7].  Low  SHBG  has  been  linked  with  an  elevated  HOMA-IR  (consistent  with
increased insulin resistance), in both men and women [4, 8 - 10].
It  is  well  established  that  rates  of  obesity  and  potentially  of  insulin  resistance  are  higher  in  more  socially
disadvantaged individuals [11 - 13]. Here, we determined whether index of multiple deprivation (IMD) as a measure of
social  disadvantage  was  associated  with  a  lower  SHBG  in  a  group  of  women  who  had  undergone  laboratory
measurement  of  SHBG.
Our hypothesis was that greater socioeconomic disadvantage relates to higher BMI and so would be associated with
lower SHBG as a marker of insulin resistance in women.
METHODS
Results of serum SHBG measurements between 1st January 2010 and 31 August 2015 from 1238 individuals were
extracted from the department’s laboratory information management system (LIMS) software (Clinisys WinPath v5.32;
Clinisys Solutions Ltd, Chertsey, Surrey, UK).
During the study period, all SHBG tests from women were included. Where there was more than one SHBG result
at  a  similar  time  point  the  first  one  was  taken.  The  assay  for  SHBG  was  performed  on  the  Abbott  Architect
immunoassay platform (Abbott Laboratories, Abbott Park, Illinois, USA). Index of multiple deprivation was derived
from the full postcode (see below).
Serum SHBG results above the limit of detection of the assay (>250 nmol/L) were excluded (n=78) on the basis that
the woman was likely taking an oestrogen containing contraceptive or hormone replacement treatment. This left a final
data set of 1,160 women.
An SHBG level of <30 nmol/L was taken as indicative of increased likelihood of impaired glucose regulation [14].
Indices of Multiple Deprivation
The  English  Indices  of  Deprivation  combine  factors  of  housing,  social  and  economic  issues  to  give  a  single
deprivation  score  for  small  areas  (known  as  Lower-Layer  Super  Output  Areas  or  LSOAs)  in  England.  An  overall
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weighted  aggregation  index  of  multiple  deprivation  (IMD)  is  generated  based  on  thirty  seven  separate  indicators,
organized across seven distinct domains of deprivation and each area is ranked from the least to most deprived. The
criteria  and  their  associated  weightings  are:  Income  deprivation,  22.5%,  Employment  deprivation,  22.5%,  Health
deprivation and disability 13.5%, Education, skills and training deprivation 13.5%, Barriers to housing and services
9.3%, Crime 9.3% and Living environment deprivation 9.3% [15].
The indices are a widely used standard measure for comparing areas across the country and can help to identify
areas  with  high  levels  of  overall  deprivation  or  areas  with  specific  concerns,  health  for  example,  that  may  not  be
recognised from the overall index. The measures of deprivation are collected nationally and published every 3-4 years,
hence data behind the 2015 IMD are for the year 2012–2013 and as such, will not reflect any policy changes, economic
changes or regeneration effects since then. In the IMD 2015, the most deprived LSOA in England is given a rank of 1
and the least deprived is ranked 32,844.
Each  SHBG  result  with  an  associated  postcode  was  linked  to  its  LSOA  using  the  geoconvert  tool  [16].
Subsequently, the 2015 indices of multiple deprivation and rank were linked to the LSOA for the specified postcode.
Statistical Analysis
The data were analysed using MedCalc (version 11.0; MedCalc Software, Belgium). The distribution of continuous
variables were assessed using frequency histograms and Kolmogorov-Smirnov normality test. Medians (interquartile
range) were presented for skewed data. The Mann-Whitney U-test was used to compare skewed data between the White
Europeans and South Asians whilst the Kruskal-Wallis test was used to compare multiple groups (with Dunn’s multiple
comparison  test  when  a  significance  difference  was  found).  Correlations  between  non-parametric  variables  and
parametric continuous variables were calculated using Spearman and Pearson correlation coefficients, respectively.
A logistic regression analysis was performed to investigate the effect  of age,  ethnicity and IMD on SHBG as a
dependent binary variable. For this analysis, SHBG was coded as 1 for values <30 nmol/L and 0 for values ≥30 nmol/L.
RESULTS
Data was analysed for  1,160 women.  Mean age was 28.7 (95% CI 28.2–29.1)  years.  The age range was 17–71
years. 48.1% women were Caucasian, 15.2% of women were of South Asian ethnicity and 2.6% of women were of
other ethnicity, including African Caribbean or African origin, while in 34.1% of women ethnicity was not known.
Circulating SHBG level increased with age (Spearman’s ρ=0.2; p<0.0001; Fig. (1)). For each 5 year increase in age
in the women studied, SHBG increased by 16.5%. There was no relation between IMD and age.
Fig. (1). Sex hormone binding globulin (SHBG) level (nmol/L) by age (years) for all women.
By quintile of IMD, SHBG was higher in the most advantaged quintile 1 of IMD (median 46 (interquartile range
29–69 nmol/L)) versus quintiles 2–5 (median 39 (26–59)) nmol/L) (H=13.55, p=0.009; Fig. (2)).
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Fig. (2). Quintiles of Index of Multiple Deprivation (IMD) versus sex hormone binding globulin (SHBG) level (nmol/L).
Quintile 1 = lowest deprivation, quintile 5 = highest deprivation. Data are presented as median (interquartile range). **: p=0.009
versus quintiles 2–5.
SHBG was  lower  in  women  of  South  Asian  ethnicity  (median  33.5  (interquartile  range  (IQR)  22–53  nmol/L))
versus White Europeans (median 42.0 (IQR 28–64); p=0.0001; Fig. (3)).
Fig. (3). Circulating sex hormone binding globulin (SHBG) level (nmol/L) by ethnic group. ***: p=0.0001 versus Caucasian group.
Women of  South  Asian  origin  were  more  likely  to  have  an  SHBG of  30  nmol/L  or  lower,  compatible  with  an
elevated risk of dysglycaemia (14) versus other ethnic groups (OR 1.93 (95% CI 1.37–2.71)). There was a negative
univariate relation between SHBG and random plasma glucose so that a lower SHBG was related to a higher plasma
glucose Spearman’s ρ -0.24, p=0.018) for the women on whom both measurements were available (n=97).
There was a  negative univariate  relation between SHBG and alanine aminotransaminase (ALT) so that  a  lower
SHBG was related to a higher ALT (Spearman’s ρ = -0.30, p<0.0001) for the 282 women on whom both measurements
were available, in keeping with the value of SHBG as a marker of hepatic protein synthesis.
Multivariate Analyses
In  multivariate  logistic  regression,  IMD women in  the quartiles  2–5 (higher  socioeconomic disadvantage)  were
more likely to have an SHBG <30 nmol/L (compatible with impaired glucose regulation) [14] versus quartile 1 (most
advantaged) (odds ratio (OR) 1.71 (95% CI: 1.17–2.53), adjusted for age (OR=0.97 (95% CI 0.95–0.98)) and ethnicity
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(for South Asian ethnicity OR=2.00 (95% CI 1.42–2.81) versus other ethnic groups).
DISCUSSION
We  have  found  that  lower  SHBG  levels  in  women  are  associated  with  a  higher  level  of  socioeconomic
disadvantage. Given the association between lower SHBG and insulin resistance in both men and women [1, 2, 4, 7, 9,
10] and the relation between low SHBG and higher plasma glucose [14], our findings are further evidence for the link
between socioeconomic disadvantage and future risk of impaired glucose regulation.
While  the  dataset  used  for  our  analysis  did  not  include  BMI or  waist  circumference  we were  able  to  include  a
significant number of women across a wide range of IMD with SHBG levels in the analysis.
The fact that the main difference between the quintiles of IMD was between quintile 1, the most advantaged, and
quintiles 2–5 of greater disadvantage poses some intriguing questions about differences in lifestyle choices between the
most advantaged quintile of the population and the other groups, particularly in relation to exercise levels, calorie intake
and efforts to maintain a healthy weight.
As previous studies have shown [17], SHBG increased by age of the woman. This relates to the progressive decline
in pancreatic beta cell function with age seen in both women and men [18]. SHBG production at the liver is profoundly
downregulated  in  relation  to  hepatic  insulinisation.  With  increasing  age,  hepatic  insulinisation  diminishes  with  a
resultant increase in hepatic SHBG production with a resultant increase in SHBG as seen here.
We and others have previously shown that SHBG levels are lower in men and women of South Asian origin [14].
The  data  reported  here  supported  this,  with  SHBG being  significantly  lower  in  women of  South  Asian  origin  as  a
marker of the well-established phenomenon of greater insulin resistance in this group compared with their Caucasian
counterparts.
Low  SHBG  concentration  is  associated  with  adverse  cardiovascular  risk  factors  [19,  20]  and  is  considered  an
independent  risk  marker  for  the  development  of  T2DM  in  women  [2,  14].  Correlations  between  low  SHBG
concentrations and hyper-insulinemia have previously been shown in both health and hyperinsulinemic disease states
such as PCOS and T2DM [21, 22]. This strong association has prompted suggestions that a low level of SHBG could be
used as a marker to identify individuals with insulin resistance [22, 23].
Weaknesses of the study are the absence of any precise phenotypic data in relation to evidence for PCOS, its cross-
sectional nature and the absence of any information about the treatments taken by the women. Nevertheless, the data
presented is robust and our finding that IMD is an independent determinant of SHBG level is valid. Any women with
very high SHBG suggestive of them taking oestrogen containing preparations were excluded.
Strengths of our study are the number of women included, the diversity of ethnicity of the women with a good
number of women of South Asian origin and the wide variation in IMD in the sample.
CONCLUSION
We  have  shown  that  lower  SHBG  levels  in  women  are  associated  with  a  higher  level  of  socioeconomic
disadvantage along with ethnic differences between Caucasian versus  South Asian origin people.  Given the known
association  between  lower  SHBG  and  higher  plasma  glucose,  our  findings  suggest  a  link  between  socioeconomic
disadvantage and future risk of type 2 diabetes.
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